Literature DB >> 28367260

A Single-blind, Split-face, Randomized, Pilot Study Comparing the Effects of Intradermal and Intramuscular Injection of Two Commercially Available Botulinum Toxin A Formulas to Reduce Signs of Facial Aging.

Priya Sapra1, Shantel Demay1, Sheetal Sapra1, Julie Khanna1, Kelli Mraud1, Jennifer Bonadonna1.   

Abstract

Objective: To examine the effectiveness of intradermal botulinum toxin type A injection in improving skin texture and midface lift while reducing pore size and sebum production, as well as investigate the differences in effectiveness between onabotulinumtoxinA and abobotulinumtoxinA using intradermal and intramuscular injection methods. Design: A 16-week, single-blind, split-face, randomized study. Each patient served as their own control, receiving onabotulinumtoxinA and abobotulinumtoxinA randomized to either the left or right side of the face. Patients received intradermal botulinum toxin type A injections at Week 0 and intramuscular botulinum toxin type A injections at Week 2. Participants: Ten women aged 35 to 65 years who exhibited static rhytids in the glabellar and periorbital area. Measurements: The primary endpoint was efficacy of split-face treatment of intradermal and intramuscular onabotulinumtoxinA and abobotulinumtoxinA as assessed by a blinded evaluator using baseline and post-treatment photographs. The secondary endpoints included safety as assessed by adverse events and patient satisfaction measured by questionnaires completed at baseline and post-treatment.
Results: Intradermal injection of botulinum toxin type A led to a statistically significant improvement in skin texture (p=0.004) while also resulting in mild midface lift (p=0.024), but did not provide a significant reduction of pore size and sebum production. There was no statistically significant difference between onabotulinumtoxinA and abobotulinumtoxinA when injected intradermally or intramuscularly.
Conclusion: Intradermal injection of botulinum toxin type A appears to be a safe and effective therapy that provides an improvement in facial skin texture and midface lift. Registry: clinicaltrials.gov (ID#: NCT02907268).

Entities:  

Year:  2017        PMID: 28367260      PMCID: PMC5367871     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  34 in total

1.  Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.

Authors:  Fredric Brandt; Neil Swanson; Leslie Baumann; Barbara Huber
Journal:  Dermatol Surg       Date:  2009-12       Impact factor: 3.398

2.  Midface lifting with botulinum toxin: intradermal technique.

Authors:  Chariya Petchngaovilai
Journal:  J Cosmet Dermatol       Date:  2009-12       Impact factor: 2.696

Review 3.  A review of onabotulinumtoxinA (Botox).

Authors:  Z Paul Lorenc; Jeffrey M Kenkel; Steven Fagien; Haideh Hirmand; Mark S Nestor; Anthony P Sclafani; Jonathan M Sykes; Heidi A Waldorf
Journal:  Aesthet Surg J       Date:  2013-03       Impact factor: 4.283

4.  Split-face double-blind study comparing the onset of action of onabotulinumtoxinA and abobotulinumtoxinA.

Authors:  Kenneth C Y Yu; Kartik D Nettar; Sumit Bapna; W John Boscardin; Corey S Maas
Journal:  Arch Facial Plast Surg       Date:  2012 May-Jun

5.  An internally controlled, double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA.

Authors:  Kartik D Nettar; Kenneth C Y Yu; Sumit Bapna; John Boscardin; Corey S Maas
Journal:  Arch Facial Plast Surg       Date:  2011-06-20

Review 6.  OnabotulinumtoxinA for Treatment of Moderate to Severe Crow's Feet Lines: A Review.

Authors:  Alastair Carruthers; Suzanne Bruce; Sue Ellen Cox; Michael A C Kane; Elisabeth Lee; Conor J Gallagher
Journal:  Aesthet Surg J       Date:  2016-03-15       Impact factor: 4.283

7.  An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.

Authors:  Joel L Cohen; Joel Schlessinger; Sue Ellen Cox; Xiaoming Lin
Journal:  Aesthet Surg J       Date:  2009-11       Impact factor: 4.283

8.  Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines.

Authors:  Boris Sommer; Ina Zschocke; Dorothee Bergfeld; Gerhard Sattler; Matthias Augustin
Journal:  Dermatol Surg       Date:  2003-05       Impact factor: 3.398

9.  Use of intradermal botulinum toxin to reduce sebum production and facial pore size.

Authors:  Anil R Shah
Journal:  J Drugs Dermatol       Date:  2008-09       Impact factor: 2.114

10.  Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids.

Authors:  Ramtin Kassir; Aparanjita Kolluru; Martin Kassir
Journal:  Dermatol Ther (Heidelb)       Date:  2013-08-16
View more
  8 in total

Review 1.  Onset and Duration of AbobotulinumtoxinA for Aesthetic Use in the Upper face: A Systematic Literature Review.

Authors:  Mark Nestor; Joel L Cohen; Marina Landau; Said Hilton; Andreas Nikolis; Syed Haq; Maurizio Viel; Bill Andriopoulos; Inna Prygova; Keith Foster; Alessio Redaelli; Philippe Picaut
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

2.  Successful Topical Application of Botulinum Toxin After Microneedling Versus Microneedling Alone for the Treatment of Atrophic Post Acne Scars: A Prospective, Split-face, Controlled Study.

Authors:  Howyda Ebrahim; Amal Elardi; Sayed Khater; Hala Morsi
Journal:  J Clin Aesthet Dermatol       Date:  2022-07

Review 3.  Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Post-hoc Analysis of the APPEAL Study.

Authors:  Riekie Smit; Elena Gubanova; Joely Kaufman; Marina Landau; Beatriz Molina; Bill Andriopoulos; Pascal Maisonobe; Inna Prygova; Alessio Redaelli
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

Review 4.  Correction of Malocclusion by Botulinum Neurotoxin Injection into Masticatory Muscles.

Authors:  Hyun Seok; Seong-Gon Kim
Journal:  Toxins (Basel)       Date:  2018-01-02       Impact factor: 4.546

5.  Intradermal Injection of Botulinum Toxin: A Safer Treatment Modality for Forehead Wrinkles.

Authors:  Ji-Young Jun; Ji-Hye Park; Choon Shik Youn; Jong Hee Lee
Journal:  Ann Dermatol       Date:  2018-06-28       Impact factor: 1.444

6.  The effect of botulinum toxin type A in different dilution on the contraction of fibroblast-In vitro study.

Authors:  Rungsima Wanitphakdeedecha; Arisa Kaewkes; Chanida Ungaksornpairote; Saowalak Limsaengurai; Uraiwan Panich; Woraphong Manuskiatti
Journal:  J Cosmet Dermatol       Date:  2019-07-22       Impact factor: 2.696

Review 7.  Botulinum Neurotoxin Type A in the Treatment of Facial Seborrhea and Acne: Evidence and a Proposed Mechanism.

Authors:  Nark-Kyoung Rho; Young-Chun Gil
Journal:  Toxins (Basel)       Date:  2021-11-19       Impact factor: 4.546

Review 8.  Microdroplet Botulinum Toxin: A Review.

Authors:  Rajat Kandhari; Ishmeet Kaur; Jyoti Gupta; Firas Al-Niaimi
Journal:  J Cutan Aesthet Surg       Date:  2022 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.